These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38169509)

  • 1. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription.
    Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
    Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
    [No Abstract]   [Full Text] [Related]  

  • 2. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.
    Li T; Su Y; Mei Y; Leng Q; Leng B; Liu Z; Stass SA; Jiang F
    Lab Invest; 2010 Feb; 90(2):234-44. PubMed ID: 20010854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
    Croker AK; Rodriguez-Torres M; Xia Y; Pardhan S; Leong HS; Lewis JD; Allan AL
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.
    Samson JM; Ravindran Menon D; Smith DE; Baird E; Kitano T; Gao D; Tan AC; Fujita M
    Chem Biol Interact; 2019 Dec; 314():108822. PubMed ID: 31580832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
    Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
    BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP.
    Trasino SE; Harrison EH; Wang TT
    Exp Biol Med (Maywood); 2007 Jun; 232(6):762-71. PubMed ID: 17526768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity.
    Gangavarapu KJ; Azabdaftari G; Morrison CD; Miller A; Foster BA; Huss WJ
    Stem Cell Res Ther; 2013 Oct; 4(5):132. PubMed ID: 24405526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenase 1A1 and 1A3 isoforms - mechanism of activation and regulation in cancer.
    Poturnajova M; Kozovska Z; Matuskova M
    Cell Signal; 2021 Nov; 87():110120. PubMed ID: 34428540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
    Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
    Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
    Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
    Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.
    Su Y; Qiu Q; Zhang X; Jiang Z; Leng Q; Liu Z; Stass SA; Jiang F
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):327-37. PubMed ID: 20142235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
    Meng E; Mitra A; Tripathi K; Finan MA; Scalici J; McClellan S; Madeira da Silva L; Reed E; Shevde LA; Palle K; Rocconi RP
    PLoS One; 2014; 9(9):e107142. PubMed ID: 25216266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH1A1 as a marker for metastasis initiating cells: A mechanistic insight.
    Datta N; Vp S; Parvathy K; A S S; Maliekal TT
    Exp Cell Res; 2024 Sep; 442(1):114213. PubMed ID: 39173941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
    Tomita H; Tanaka K; Tanaka T; Hara A
    Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.
    Cojoc M; Peitzsch C; Kurth I; Trautmann F; Kunz-Schughart LA; Telegeev GD; Stakhovsky EA; Walker JR; Simin K; Lyle S; Fuessel S; Erdmann K; Wirth MP; Krause M; Baumann M; Dubrovska A
    Cancer Res; 2015 Apr; 75(7):1482-94. PubMed ID: 25670168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALDH1A1 and ALDH1A3 paralogues of aldehyde dehydrogenase 1 control myogenic differentiation of skeletal muscle satellite cells by retinoic acid-dependent and -independent mechanisms.
    Steingruber L; Krabichler F; Franzmeier S; Wu W; Schlegel J; Koch M
    Cell Tissue Res; 2023 Dec; 394(3):515-528. PubMed ID: 37904003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and clinical relevance of ALDHbright populations in prostate cancer.
    Le Magnen C; Bubendorf L; Rentsch CA; Mengus C; Gsponer J; Zellweger T; Rieken M; Thalmann GN; Cecchini MG; Germann M; Bachmann A; Wyler S; Heberer M; Spagnoli GC
    Clin Cancer Res; 2013 Oct; 19(19):5361-71. PubMed ID: 23969936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
    Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
    Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.